IN2003CH00929A - - Google Patents

Download PDF

Info

Publication number
IN2003CH00929A
IN2003CH00929A IN929CH2003A IN2003CH00929A IN 2003CH00929 A IN2003CH00929 A IN 2003CH00929A IN 929CH2003 A IN929CH2003 A IN 929CH2003A IN 2003CH00929 A IN2003CH00929 A IN 2003CH00929A
Authority
IN
India
Prior art keywords
sub
pcaf
mum
compounds
useful
Prior art date
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IN929CH2003 priority Critical patent/IN2003CH00929A/en
Priority to PCT/IB2004/052294 priority patent/WO2005047457A2/en
Priority to AT04799059T priority patent/ATE549309T1/en
Priority to US10/579,219 priority patent/US7402706B2/en
Priority to EP04799059A priority patent/EP1694622B1/en
Publication of IN2003CH00929A publication Critical patent/IN2003CH00929A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/687—Unsaturated compounds containing a keto groups being part of a ring containing halogen
    • C07C49/697—Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)

Abstract

In this patent we describe the purification of prenylated benzophenones from the fruit rinds of Garcinia species and its evaluation as an inhibitor for Histone acetyltransferases p300 and PCAF. We have found that prenylated benzophenones are potent HAT inhibitors of p300 (IC<SUB>50</SUB>-1 muM) and pCAF (IC<SUB>50</SUB>-15 muM). The inhibitors significantly repress the p300 HAT dependent transcriptional activation from in vitro assembled chromatin template but had no effect on transcription from DNA. These results suggest that the compounds could be specific to HATs. Thus these compounds should be useful as biological switching molecule for evaluating the role of p300 and PCAF in cellular functions and may be useful as new chemical entities for the development of anticancer drugs.
IN929CH2003 2003-11-13 2003-11-13 IN2003CH00929A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IN929CH2003 IN2003CH00929A (en) 2003-11-13 2003-11-13
PCT/IB2004/052294 WO2005047457A2 (en) 2003-11-13 2004-11-04 Polyisoprenyl benzophenones as inhibitors of histone acetyl transferases and uses thereof
AT04799059T ATE549309T1 (en) 2003-11-13 2004-11-04 POLYISOPREVONL BENZOPHENONE AS INHIBITORS OF HISTONE ACETYLTRANSDFERASES AND APPLICATIONS THEREOF
US10/579,219 US7402706B2 (en) 2003-11-13 2004-11-04 Polyisoprenylated benzophenones and their isomers as inhibitors of histone acetyltransferases and uses thereof
EP04799059A EP1694622B1 (en) 2003-11-13 2004-11-04 Polyisoprenyl benzophenones as inhibitors of histone acetyl transferases and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN929CH2003 IN2003CH00929A (en) 2003-11-13 2003-11-13

Publications (1)

Publication Number Publication Date
IN2003CH00929A true IN2003CH00929A (en) 2008-10-06

Family

ID=34586954

Family Applications (1)

Application Number Title Priority Date Filing Date
IN929CH2003 IN2003CH00929A (en) 2003-11-13 2003-11-13

Country Status (5)

Country Link
US (1) US7402706B2 (en)
EP (1) EP1694622B1 (en)
AT (1) ATE549309T1 (en)
IN (1) IN2003CH00929A (en)
WO (1) WO2005047457A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022254465A1 (en) * 2021-06-02 2022-12-08 Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) Small molecule modulator targeting a rare histone modification regulating adipogenesis and pharmaceutical formulation thereof

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006270322A1 (en) 2005-07-14 2007-01-25 Takeda San Diego, Inc. Histone deacetylase inhibitors
AR057579A1 (en) * 2005-11-23 2007-12-05 Merck & Co Inc SPIROCICLICAL COMPOUNDS AS INHIBITORS OF ACETYLASE HISTONE (HDAC)
KR101005173B1 (en) * 2008-02-18 2011-01-04 인제대학교 산학협력단 Fraction from stem bark of Vietnamese medicinal plant Garcinia oblongifoliaClusiaceae and compounds isolated therefrom having antioxidant and cytotoxic activities
CN102575236B (en) * 2009-09-07 2014-10-01 贾瓦哈拉尔尼赫鲁高级科学研究中心 Inhibition of histone acetyltransferases by CTK7A and methods thereof
JP5804432B2 (en) 2010-12-09 2015-11-04 インダス・バイオテック・プライベート・リミテッド Complex of garcinol and cyclodextrin and method thereof
WO2013148114A1 (en) * 2012-03-30 2013-10-03 University Of Florida Research Foundation, Inc. P300/cbp inhibitors and methods of use
GB201215942D0 (en) * 2012-09-06 2012-10-24 Glaxo Group Ltd Method of treatent
JP2020525425A (en) * 2017-06-22 2020-08-27 サミ ラブズ リミテッド Garcinol composition for therapeutic management of endoplasmic reticulum stress
DK3681885T3 (en) 2017-09-15 2024-04-15 Forma Therapeutics Inc TETRAHYDRO-IMIDAZO-QUINOLINE COMPOUNDS AS CBP/P300 INHIBITORS
CN116178369A (en) 2018-06-29 2023-05-30 福马疗法公司 Inhibition of CREB Binding Protein (CBP)
US11801243B2 (en) 2020-09-23 2023-10-31 Forma Therapeutics, Inc. Bromodomain inhibitors for androgen receptor-driven cancers
US11795168B2 (en) 2020-09-23 2023-10-24 Forma Therapeutics, Inc. Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08259493A (en) * 1995-03-20 1996-10-08 Sugimoto Masami Anti-mrsa active substance

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022254465A1 (en) * 2021-06-02 2022-12-08 Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) Small molecule modulator targeting a rare histone modification regulating adipogenesis and pharmaceutical formulation thereof

Also Published As

Publication number Publication date
WO2005047457B1 (en) 2005-12-01
US20070254961A1 (en) 2007-11-01
EP1694622A2 (en) 2006-08-30
EP1694622B1 (en) 2012-03-14
WO2005047457A3 (en) 2005-08-04
WO2005047457A2 (en) 2005-05-26
US7402706B2 (en) 2008-07-22
ATE549309T1 (en) 2012-03-15

Similar Documents

Publication Publication Date Title
IN2003CH00929A (en)
CY1110498T1 (en) PYRAZOLIS PRODUCERS AS TOROSINE CINASES INHIBITORS
CY2014028I1 (en) COMPOUNDS, PHARMACEUTICAL FORMS AND METHODS FOR THE TREATMENT OR PREVENTION OF ACNE ROSEPHUM
NO20055741L (en) New chemical compounds
DE602004021685D1 (en) FLAG-FREE DETECTION OF BIOLOGICAL AND CHEMICAL SUBSTANCES BY EVANESCENCE FIELD
ATE386028T1 (en) CYCLOHEXYLSULPHONES AS GAMMA SECRETASE INHIBITORS
UY27993A1 (en) DERIVATIVES OF 4-PIRROLIDINO-FENIL-BENCIL ETER
ATE347451T1 (en) DISPENSING DEVICE
ATE542804T1 (en) 5-PHENYL-PENTOIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS FOR THE TREATMENT OF ASTHMA AND OTHER DISEASES
ATE424823T1 (en) 4-PHENYL-5-OXO-1,4,5,6,7,8-HEXAHYDROCINOLINE DERIVATIVES AS MEDICINAL PRODUCTS FOR THE TREATMENT OF INFERTILITY
ATE422201T1 (en) 4-(HETEROCYCLYL)-BENZENESULFOXIMINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISEASES
SE0302304D0 (en) Novel compounds
ATE406895T1 (en) 4-PHENYL-5-OXO-L,4,5,6,7,8-HEXAHYDROCINOLINE DERIVATIVES AS MEDICINAL PRODUCTS FOR THE TREATMENT OF INFERTILITY
DE602004023623D1 (en) CHIRAL COMPOUNDS AND COMPOSITIONS CONTAINING THEM
DK1778622T3 (en) Para-alkyl-substituted N- (4-hydroxy-3-methoxy-benzyl) -cinnamic acid amides and their use in the preparation of drugs
DE602004006118D1 (en) 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBOXYL ACID DERIVATIVES AS GAMMA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER
ITRN20030024A1 (en) DEVICE FOR THE COLLECTION OF BIOLOGICAL AND / OR CHEMICAL SAMPLES.
NO20031844D0 (en) New ascorbic acid compounds, synthesis methods and their use
MX2008008470A (en) Novel pyrrole derivatives with histone deacetylase inhibitor activity.
ITFI20020034A1 (en) METHOD AND DEVICE FOR THE SPECTRAL ANALYSIS OF AN ECOGRAPHIC SIGNAL
DE60331359D1 (en) KYNURENINE 3-HYDROXYLASE INHIBITORS FOR THE TREATMENT OF DIABETES
DK1658494T3 (en) A method for in vitro titration of an NCTA and its use in a method for the evaluation and / or monitoring of a biological product production method
DK1682482T3 (en) PROCEDURE FOR IMPROVING THE DISTRIBUTION CHARACTERISTICS OF FEDERAL ALCOHOL COMPOUNDS, PRODUCTS, AND APPLICATIONS THEREOF
RU2003113761A (en) ANTI-INFLAMMATORY PRODUCT
DE602004026067D1 (en) Device for the treatment of feet